13th St. Gallen international breast cancer conference 2013: Primary therapy of early breast cancer evidence, controversies, consensus - Opinion of a German team of experts (Zurich 2013)

Breast Care

Volumn 8, Issue 3, 2013, Pages 221-229

  Untch, Michael ^a   Gerber, Bernd ^b   Harbeck, Nadia ^c   Jackisch, Christian ^d   Marschner, Norbert ^b   Möbus, Volker ^e   Von Minckwitz, Gunter ^e,f,g   Loibl, Sibylle ^f   Beckmann, Matthias W ^h   Blohmer, Jens Uwe ⁱ   Costa, Serban Dan ^j   Decker, Thomas ^k   Diel, Ingo ^l   Dimpfl, Thomas ^m   Eiermann, Wolfgang ⁿ   Fehm, Tanja ^o   Friese, Klaus ^p   Jänicke, Fritz ^q   Janni, Wolfgang ^r   Jonat, Walter ^s   Kiechle, Marion ^t   Köhler, Uwe ^u   Lück, Hans Joachim ^v   Maass, Nicolai ^w   Possinger, Kurt ^x   Rody, Achim ^s   Scharl, Anton ^y   Schneeweiss, Andreas ^z   Thomssen, Christoph ^aa   Wallwiener, Diethelm ^ab   Welt, Anja ^ac   more..

^a HELIOS KLINIKUM BERLIN BUCH   (Germany)

^b Universitätsfrauenklinik Rostock ^*  (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Klinikum Offenbach   (Germany)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f GERMAN BREAST GROUP   (Germany)

^g Senologische Onkologie   (Germany)

^h UNIVERSITY HOSPITAL ERLANGEN   (Germany)

ⁱ MARTIN LUTHER KRANKENHAUS   (Germany)

^j UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^k Gemeinschaftspraxis Onkologie   (Germany)

^l Gemeinschaftspraxis Gynäkologie und Geburtshilfe   (Germany)

^m Klinik für Frauenheilkunde und Geburtshilfe   (Germany)

ⁿ Interdisciplinary Oncology Center   (Germany)

^o UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^p LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^q UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^r UNIVERSITY HOSPITAL ULM   (Germany)

^s UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^t TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^u Klinikum St Georg   (Germany)

^v Gynäkologisch Onkologische Praxis Hannover   (Germany)

^w UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^x CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^y Frauenklinik   (Germany)

^z Nationales Centrum für Tumorerkrankungen NCTund Universitä tsfrauenklinik Heidelberg   (Germany)

^aa MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^ab UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^ac UNIVERSITY HOSPITAL ESSEN   (Germany)

more..

Author keywords

Adjuvant therapy; Early breast cancer; Multigene signatures; St. Gallen Consensus; Targeted therapy

Indexed keywords

ANTHRACYCLINE; BISPHOSPHONIC ACID DERIVATIVE; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB; ZOLEDRONIC ACID; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CALCIFICATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; CLINICAL PRACTICE; CONSENSUS; DISEASE FREE SURVIVAL; DOSE DENSIFICATION; EARLY CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FAMILY HISTORY; GERMANY; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; INFLAMMATORY BREAST CANCER; INTRADUCTAL CARCINOMA; IRRADIATION; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; LYMPHOCYTIC INFILTRATION; MOLECULAR DIAGNOSTICS; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; OVARIAN PRESERVATION; OVARY FUNCTION; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL (TOPIC); POSTMENOPAUSE; PRIORITY JOURNAL; RECURRENCE RISK; SENTINEL LYMPH NODE; SWITZERLAND; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT INDICATION; TRIPLE NEGATIVE BREAST CANCER; ADJUVANT CHEMOTHERAPY; AXILLARY LYMPH NODE; CANCER RADIOTHERAPY; CONSENSUS DEVELOPMENT; FOLLOW UP; LYMPH NODE IRRADIATION; MASTECTOMY; MEDICAL EXPERT; MOLECULAR PATHOLOGY; STROMA; THORAX WALL;

EID: 84880741094     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000351692     Document Type: Article

References (12)

1. www.ago-online.de
2. Ho AY, Gupta G, King TA, Perez CA, et al.: Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy. Cancer 2012;118: 4944-4952.
3. Millar EKA et al.: Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. JCO 2009;27: 4701-4708.
4. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, et al.: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305: 569-575.
5. Kühn T et al.: Sentinel lymph node biopsy before or after neoadjuvant chemotherapy -final results from the prospective German, multiinstitutional SENTINA-trial. SABCS 2012, S2-2.
6. Boughey JC et al.: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy -results from the ACOSOG Z1071 trial. SABCS 2012, S2-1.
7. Haviland JS et al.: The UK START (Standardisation of Breast Radiotherapy) trials: 10-year-followup results. SABCS 2012, S4-1.
8. Gluz O et al.: Prospective comparison of risk assessment tools in early breast cancer (recurrence score, uPA/PAI-1, central grade, and luminal subtypes): final correlation analysis from the phase III WSG-Plan B trial. SABCS 2011, S4-3.
9. Kelly KM, et al.: Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic classifier® in early-stage estrogen receptor-positive breast cancer. Oncologist 2012;17: 492-498.
10. Möbus V et al.: Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase II study. JCO 2010;28: 2874-2880.
11. Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, et al.: Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med 2009;360: 679-691.
12. Gnant M et al.: Long-term follow-up in ABCSG- 12: significantly improved overall survival with adjuvant zoledronic acid in premenopausal patients with endocrine-receptor-positive early breast cancer. SABCS 2011, S1-2.